Frank Fleming

721 total citations
9 papers, 501 citations indexed

About

Frank Fleming is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Clinical Psychology. According to data from OpenAlex, Frank Fleming has authored 9 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 4 papers in Cognitive Neuroscience and 2 papers in Clinical Psychology. Recurrent topics in Frank Fleming's work include Schizophrenia research and treatment (6 papers), Healthcare Decision-Making and Restraints (2 papers) and Functional Brain Connectivity Studies (2 papers). Frank Fleming is often cited by papers focused on Schizophrenia research and treatment (6 papers), Healthcare Decision-Making and Restraints (2 papers) and Functional Brain Connectivity Studies (2 papers). Frank Fleming collaborates with scholars based in United States. Frank Fleming's co-authors include Nancy C. Andreasen, Stephan Arndt, David J. Moser, Susan K. Schultz, Michelle L. Benjamin, Del D. Miller, Paul S. Appelbaum, Jane S. Paulsen, Michael Flaum and Beng‐Choon Ho and has published in prestigious journals such as American Journal of Psychiatry, Psychological Medicine and Neuropsychopharmacology.

In The Last Decade

Frank Fleming

9 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank Fleming United States	7	206	190	110	87	76	9	501
Nikos C. Stefanis Greece	13	258 1.3×	135 0.7×	64 0.6×	45 0.5×	76 1.0×	48	609
Peretz Barak Israel	7	269 1.3×	154 0.8×	53 0.5×	53 0.6×	49 0.6×	10	502
Taha Amir Kuwait	8	245 1.2×	149 0.8×	74 0.7×	67 0.8×	39 0.5×	15	529
F. Rouillon France	11	177 0.9×	152 0.8×	57 0.5×	43 0.5×	27 0.4×	35	487
F J Dunne United Kingdom	11	160 0.8×	118 0.6×	66 0.6×	81 0.9×	46 0.6×	23	472
René Bridler Switzerland	11	234 1.1×	240 1.3×	32 0.3×	58 0.7×	96 1.3×	35	566
Joëlle A. Pasman Netherlands	12	296 1.4×	226 1.2×	67 0.6×	109 1.3×	23 0.3×	28	623
Evelyn Bromet United States	7	407 2.0×	190 1.0×	143 1.3×	83 1.0×	45 0.6×	11	634
Ümit Başar Semiz Türkiye	15	340 1.7×	320 1.7×	163 1.5×	43 0.5×	30 0.4×	53	737
Anton Grech Malta	10	366 1.8×	111 0.6×	135 1.2×	47 0.5×	33 0.4×	31	591

Countries citing papers authored by Frank Fleming

Since Specialization

Citations

This map shows the geographic impact of Frank Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Fleming more than expected).

Fields of papers citing papers by Frank Fleming

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Fleming. The network helps show where Frank Fleming may publish in the future.

Co-authorship network of co-authors of Frank Fleming

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Fleming. A scholar is included among the top collaborators of Frank Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Fleming. Frank Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Ellingrod, Vicki L., Del D. Miller, Brian C. Lund, et al.. (2025). 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia. Psychopharmacology Bulletin. 37(2). 109–112. 1 indexed citations

Wassink, Thomas H., Eric A. Epping, Danielle S. Rudd, et al.. (2012). Influence of ZNF804a on Brain Structure Volumes and Symptom Severity in Individuals With Schizophrenia. Archives of General Psychiatry. 69(9). 885–885. 42 indexed citations

Ellingrod, Vicki L., Paul J. Perry, John C. Ringold, et al.. (2005). Weight gain associated with the −759C/T polymorphism of the 5HT2C receptor and olanzapine. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 134B(1). 76–78. 112 indexed citations

Moser, David J., Susan K. Schultz, Michelle L. Benjamin, et al.. (2005). Informed Consent in Medication-Free Schizophrenia Research. American Journal of Psychiatry. 162(6). 1209–1211. 21 indexed citations

Chemerinski, Erán, Beng‐Choon Ho, Michael Flaum, et al.. (2002). Insomnia as a predictor for symptom worsening following antipsychotic withdrawal in schizophrenia. Comprehensive Psychiatry. 43(5). 393–396. 71 indexed citations

Moser, David J., Susan K. Schultz, Stephan Arndt, et al.. (2002). Capacity to Provide Informed Consent for Participation in Schizophrenia and HIV Research. American Journal of Psychiatry. 159(7). 1201–1207. 161 indexed citations

Schultz, Susan K., Vicki L. Ellingrod, Frank Fleming, & Nancy C. Andreasen. (2001). The association between risk factors for tardive dyskinesia and phenylalanine‐induced abnormal movements in schizophrenia. Human Psychopharmacology Clinical and Experimental. 16(3). 273–277. 1 indexed citations

Swayze, Victor W., Arnold E. Andersen, Stephan Arndt, et al.. (1996). Reversibility of brain tissue loss in anorexia nervosa assessed with a computerized Talairach 3-D proportional grid. Psychological Medicine. 26(2). 381–390. 66 indexed citations

Miller, Del D., Michael Flaum, Stephan Arndt, Frank Fleming, & Nancy C. Andreasen. (1994). Effect of Antipsychotic Withdrawal on Negative Symptoms in Schizophrenia. Neuropsychopharmacology. 11(1). 11–20. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact